David J. Pinato, MD, PhD

David J. Pinato, MD, discusses guidelines for toxicity management in hepatocellular carcinoma (HCC).

David J. Pinato, MD, PhD, discusses the lack of biomarkers in hepatocellular carcinoma.

David J. Pinato, MD, PhD, clinical senior lecturer in medical oncology, clinician scientist, consultant medical oncologist, Department of Surgery and Cancer, Imperial College London, discusses the molecular makeup of the tumor microenvironment in neuroendocrine malignancies.

David J. Pinato, MD, PhD, NIHR Academic Clinical Lecturer in Medical Oncology, resident, Royal Brompton Hospital and Imperial College London, discusses an analysis of intra-tumor heterogeneity in primary and metastatic hepatocellular carcinoma (HCC).